Personalis, Inc. Profile Avatar - Palmy Investing

Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides…

Medical - Diagnostics & Research
US, Menlo Park [HQ]

News

Theses · Events · Sentiments
Sentiments
25-01-13 9.00%

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London's Francis Crick Institute …

End of PSNL's Analysis
CIK: 1527753 CUSIP: 71535D106 ISIN: US71535D1063 LEI: - UEI: -
Secondary Listings
PSNL has no secondary listings inside our databases.